Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 7 December 2022, 06:00 HKT/SGT
Share:
    

Source: NUNMN
NUNMN and Nulab Technology LTD. Supplements Opening Their Online Store to the Hong Kong Market

HONG KONG, Dec 7, 2022 - (ACN Newswire) - NUNMN, part of Nulab Technology Ltd., is a rapidly-expanding company in Canada that offers 99.5% pure NMN supplements and they are now available in the Hong Kong market. Previously only sold throughout Canada and the US, Nulab Technology LTD has decided to expand its sales and provide NMN supplements to customers in Hong Kong, as an entry point to the Asian market.


During a recent interview, Nulab Technology LTD president Alan M. had this to say: ''Each year, the supplement receives a high volume of new users from all corners of the world. We have had inquiries from Asia, Africa, Europe and South America, Oceania & North America. All our products are authorized by Health Canada as they improve health performance and meet consumer demands. Hong Kong is just part of the second phase of our global expansion plan!"

According to Alan M., NUNMN and Nulab Technology LTD's recent expansion is only the start. They have already initiated market research to gain a foothold in the European and South American markets as well.

Nulab Technology LTD's president said that originally starting in Canada as a health supplement supplier, they have now reached customers all over the world with their global network and website.

Now that they have consistent customers in Canada and that the US market is growing, they have brought the business to a point where expanding makes even more sense. After months of research, testing, and preparation, they are officially opening their online store to the Hong Kong market.

About NUNMN & Nulab Technology LTD

NUNMN is a leading beauty and wellness company with offices in Canada, the US, and soon in Hong Kong. They are committed to redefining wellness and chronological age in terms of biological age.

David Sinclair, Professor of Genetics at Harvard Medical School, discovered that NMN (99.5%) can be widely consumed to improve health and metabolism, and brain function as well as cardiovascular improvement.

The nicotinamide mononucleotide (NMN) molecule is converted into the vital and well-known chemical compound nicotinamide adenine dinucleotide (NAD+). The human body uses NAD+ to fuel a plethora of processes, including DNA damage repair, energy production, and boosting immunity. Therefore, it aids in maintaining high metabolism and keeping overall bodily functions healthy.

Media Contact:
Alan M.
Email: hello@nunmn.com
Website: https://nunmn.com/zh/
Phone: 1(888) 666-6851


Topic: Press release summary
Source: NUNMN

Sectors: Retail & eCommerce, Food & Beverage, Daily News, Local Biz, Beauty & Skin Care
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
OMP's AI-driven Unison Planning(TM) Platform Enhances Supply Chain Agility for McCormick & Co.  
Dec 3, 2025 22:00 HKT/SGT
The 26th Hong Kong Forum marks successful completion  
Wednesday, December 3, 2025 9:44:00 PM
DesignInspire opens today, showcasing over 260 local and global design brands  
Dec 3, 2025 20:52 HKT/SGT
Focus Graphite Appoints Renowned Battery Executive Dr. Sunho Kang as Strategic Advisor for Cell Technology  
Dec 3, 2025 18:09 HKT/SGT
Anime Tokyo Station: Celebrating the 25th Anniversaries of Two Popular Anime with an Anniversary Joint Exhibition Starting November 15  
Wednesday, December 3, 2025 10:30:00 AM
Polytek Engineering Selected as ORCA's Exclusive Distributor and Service Partner for Hong Kong  
Dec 3, 2025 07:00 HKT/SGT
Doubleview Provides Cobalt Resource Summary for the Hat Polymetallic Deposit in Advance of Updated MRE and PEA  
Dec 2, 2025 21:59 HKT/SGT
OpenAI Joins the Global Anti-Scam Alliance as Foundation Member to Strengthen Global Response Against AI-Enabled Scams  
Dec 2, 2025 21:00 HKT/SGT
Digital Realty and BW Digital Partner to Support Expansion of Cross-Border Connectivity Between Singapore and Batam  
Dec 2, 2025 15:49 HKT/SGT
GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer's and Other Neurodegenerative Diseases  
Dec 2, 2025 13:00 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: